Mitochondrial mass of circulating NK cells as a novel biomarker in severe SARS-CoV-2 infection.

Wang, Bingqi; Chen, Zhenni; Huang, Yiran; Ding, Jiayi; Lin, Yingrui; Wang, Min; Li, Xianping

Wang, Bingqi; Chen, Zhenni; Huang, Yiran; Ding, Jiayi; Lin, Yingrui; Wang, Min; Li, Xianping.

Afiliação

Wang B; Department of Laboratory Medicine, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
Chen Z; Department of Laboratory Medicine, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
Huang Y; School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China.
Ding J; Department of Laboratory Medicine, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
Lin Y; Department of Laboratory Medicine, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
Wang M; Department of Laboratory Medicine, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
Li X; Department of Laboratory Medicine, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China. Electronic address: xianpingli2017@csu.edu.cn.

Int Immunopharmacol ; 124(Pt A): 110839, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37639852

Assuntos

COVID-19; Humanos; SARS-CoV-2; Células Matadoras Naturais; Biomarcadores; Prognóstico

Palavras-chave

COVID-19; Immunosurveillance; Mitochondria; Natural killer cell; Severity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Int Immunopharmacol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google